Giovanni Di Minno Selected Research

Rivaroxaban

7/2015	Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient?
11/2012	[New oral anticoagulants: recommendations, precautions and perspectives for use].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Di Minno Research Topics

Disease

31	Hemorrhage 12/2021 - 01/2006
28	Hemophilia A (Haemophilia) 06/2022 - 01/2007
12	Thrombosis (Thrombus) 01/2020 - 09/2002
9	Thrombasthenia (Glanzmann Thrombasthenia) 07/2019 - 12/2004
9	Venous Thromboembolism 01/2019 - 11/2006
8	Stroke (Strokes) 04/2017 - 04/2011
7	Neoplasms (Cancer) 01/2019 - 04/2011
7	Atrial Fibrillation 06/2017 - 01/2012
5	Vascular Diseases (Vascular Disease) 06/2015 - 09/2002
4	Venous Thrombosis (Deep-Vein Thrombosis) 07/2019 - 04/2003
4	Thrombophilia 08/2014 - 08/2002
3	Psoriatic Arthritis 05/2012 - 03/2011
2	Splenomegaly 12/2021 - 11/2017
2	Joint Diseases (Joint Disease) 01/2021 - 07/2011
2	Peripheral Arterial Disease 01/2021 - 01/2010
2	Pain (Aches) 01/2021 - 07/2011
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2019 - 05/2010
2	Renal Insufficiency (Renal Failure) 01/2019 - 04/2017
2	Hematologic Neoplasms (Hematological Malignancy) 11/2017 - 04/2011
2	Chronic Renal Insufficiency 06/2017 - 05/2010
2	Hyperhomocysteinemia 09/2013 - 10/2011
2	Factor VII Deficiency (Hypoproconvertinemia) 04/2013 - 02/2013
2	Acute Coronary Syndrome 11/2012 - 08/2009
2	Atherosclerosis 07/2012 - 03/2011
2	Inflammation (Inflammations) 07/2012 - 03/2011
2	Diabetic Angiopathies (Diabetic Angiopathy) 03/2012 - 01/2004
2	Embolic Stroke 01/2012 - 11/2011
2	Thrombocytopenia (Thrombopenia) 04/2011 - 03/2007
2	Ischemic Stroke 04/2011 - 01/2002
2	Coronary Disease (Coronary Heart Disease) 10/2010 - 09/2002
2	Myocardial Infarction 10/2010 - 09/2002
2	Sudden Death 10/2010 - 09/2002
2	Hypercholesterolemia 07/2005 - 10/2004
1	COVID-19 02/2022
1	Hematoma 12/2021
1	Disease Susceptibility (Diathesis) 12/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2019
1	Pneumonia (Pneumonitis) 01/2019

Drug/Important Bio-Agent (IBA)

12	Factor VIII (Coagulation Factor VIII)IBA 06/2022 - 01/2007
11	recombinant FVIIa (rFVIIa)FDA Link 07/2019 - 12/2004
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 08/2002
9	AnticoagulantsIBA 01/2019 - 11/2011
8	Factor VIIa (Activated Factor VII)IBA 01/2020 - 01/2006
8	AntibodiesIBA 07/2019 - 01/2006
6	Warfarin (Coumadin)FDA LinkGeneric 12/2015 - 02/2012
5	Blood Coagulation Factors (Coagulation Factor)IBA 12/2021 - 08/2011
5	Pharmaceutical PreparationsIBA 11/2021 - 01/2010
5	Prothrombin (Factor II)IBA 01/2020 - 01/2002
4	emicizumabIBA 11/2021 - 01/2019
4	AutoantibodiesIBA 01/2020 - 01/2010
4	Thrombin FDA Link 01/2020 - 11/2012
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 08/2009
4	IntegrinsIBA 08/2018 - 12/2009
4	Dabigatran FDA Link 06/2017 - 11/2012
4	Vitamin K FDA Link 01/2017 - 11/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012 - 03/2011
3	Clopidogrel (Plavix)FDA Link 01/2021 - 08/2009
3	Antiphospholipid AntibodiesIBA 07/2019 - 05/2010
3	Rituximab (Mabthera)FDA Link 11/2017 - 01/2015
3	AntithrombinsIBA 06/2017 - 01/2014
3	Platelet Membrane Glycoprotein IIbIBA 04/2016 - 01/2006
3	Folic Acid (Vitamin M)FDA LinkGeneric 06/2015 - 10/2005
3	Protein SIBA 05/2015 - 04/2003
3	factor V LeidenIBA 01/2014 - 01/2002
2	human F8 protein FDA Link 06/2022 - 01/2020
2	CollagenIBA 12/2021 - 03/2007
2	Factor V (Coagulation Factor V)IBA 12/2021 - 01/2002
2	Factor VII (Proconvertin)IBA 12/2021 - 04/2013
2	TicagrelorIBA 01/2021 - 06/2013
2	fitusiranIBA 01/2020 - 01/2019
2	concizumabIBA 01/2020 - 01/2019
2	Fibrinogen ReceptorsIBA 07/2017 - 04/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 04/2016 - 06/2015
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 04/2016 - 08/2015
2	Monoclonal AntibodiesIBA 01/2016 - 01/2015
2	apixabanIBA 07/2015 - 11/2012
2	RivaroxabanIBA 07/2015 - 11/2012
2	Protein CIBA 05/2015 - 01/2014
2	HomocysteineIBA 05/2010 - 01/2002
2	Heparin (Liquaemin)FDA LinkGeneric 08/2009 - 08/2002
2	Hemostatics (Antihemorrhagics)IBA 03/2007 - 01/2006
2	CholesterolIBA 07/2005 - 10/2004
1	Arachidonic Acid (Vitamin F)IBA 12/2021
1	RistocetinIBA 12/2021
1	Factor XIII (Coagulation Factor XIII)IBA 12/2021
1	Factor X (Stuart Factor)IBA 12/2021
1	Thromboplastin (Tissue Factor)IBA 12/2021
1	VaccinesIBA 07/2019
1	Zoledronic Acid (Zometa)FDA Link 01/2019

Therapy/Procedure

13	Therapeutics 01/2021 - 11/2006
5	Platelet Transfusion (Blood Platelet Transfusions) 07/2019 - 01/2006
3	Secondary Prevention 04/2017 - 09/2002
2	Surgical Amputation (Amputations) 01/2021 - 11/2014
2	Precision Medicine 01/2020 - 01/2017
2	Operative Surgical Procedures 04/2016 - 08/2015
1	Critical Care (Surgical Intensive Care) 02/2022
1	Injections 07/2021
1	Pain Management 01/2021
1	Intravenous Infusions 01/2020
1	Subcutaneous Injections 01/2020